$Core Scientific, Inc.(CORZ.US) The core reason for the sudden pre-market drop in Core Scientific (CORZ) was not a deterioration in the company's fundamentals but rather a repricing of the "all-stock acquisition" deal details and rapid position adjustments by arbitrage traders:

1. The value of the stock swap transaction fluctuates with CoreWeave's stock price.

• In the early hours of July 7, CoreWeave announced it would acquire CORZ in an all-stock deal, with an initial per-share consideration of approximately $20.40 at the time of the announcement. The actual amount received is determined by the exchange ratio × CoreWeave's stock price on the day.

• After the announcement, CoreWeave (CRWV) fell nearly 9% in pre-market trading, directly pushing CORZ's "theoretical value" from above $20 down to the $16–17 range. Quant/arbitrage funds quickly sold CORZ and bought CRWV to hedge the spread, causing CORZ to plummet pre-market. 

2. Extremely low pre-market liquidity amplified the volatility.

• Pre-market trading volume in U.S. stocks is typically only 3–5% of regular trading volume. Large orders can quickly deplete the order book, leading to temporary price distortions. Once trading volume returns to normal levels, the stock price often reverts to near the swap value.

3. The deal still faces multiple uncertainties.

• The merger requires shareholder and regulatory approval and is expected to take 4–6 months to complete. If CRWV's stock price continues to decline during this period, CORZ's consideration will also be adjusted downward.

• The market has begun to discount the likelihood of the merger's success and the timeline for regulatory review, leading arbitrage traders to place orders at a 5–10% discount range, further suppressing pre-market quotes.